A new ceramide and a new biflavonoid named parinaramide (1) and sparinaritin (2), respectively, have been isolated along with ten known compounds, kaempferol, quercetin, taxifolin, taxifolin-3-O-rhamnoside, lupeol, betulinic acid, ursolic acid, 2α-hydroxy-ursolic acid, 2,3-dihydroxy-1-(4-hydroxy-3,5dimethoxyphenyl)-1-propanone, and sucrose, from the leaves of Parinari hypochrysea (Chrysobalanaceae). Structures were determined using 1D-and 2D-NMR, MS and by chemical analysis. The methanol extract of leaves, stem bark and roots of P. hypochrysea were screened for their antioxidant and lipoxygenase inhibition potential and found to be inactive.
The family Chrysobalanaceae includes about 17 genera and 525 species, growing mainly in tropical and subtropical regions, especially in the New World [1] . Members of the genus Parinari are distributed worldwide and used in several countries to treat different diseases such as diabetes, dysentery, malaria, toothache and venereal diseases [2, 3, 4] . Biological screening of extracts of Parinari spp. has shown antimicrobial [5, 6] , antimalarial [2] and cytotoxic activities [7] . To our knowledge, phytochemical studies on P. hypochrysea have not been reported to date. In our effort to obtain bioactive or new compounds from Cameroonian medicinal plants, we have investigated the leaves of P. hypochrysea. In this contribution, we report the isolation and structure elucidation of a new ceramide, parinaramide (1) , and a new biflavonoid, sparinaritin (2) whose structures were elucidated on the basis of spectroscopic and chemical analysis. In addition, the ten known compounds kaempferol, quercetin, taxifolin, taxifolin-3-O-rhamnoside, lupeol, ursolic acid, betulinic acid, 2α-hydroxy-ursolic acid, 2,3-dihydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-1-propanone and sucrose were also isolated.
The air-dried leaves of P. hypochrysea were extracted with methanol. After removal of the solvent by evaporation, the concentrated extract was subjected to successive chromatographic separation to give ten known compounds, and two novel ones, a ceramide 1, and a biflavonoid 2.
Compound 1 was obtained as a white amorphous powder. Its FAB-MS showed a [M+H 2 O] + peak at m/z = 797.9, indicating a molecular formula of C 49 H 99 NO 6 with two degrees of unsaturation. The molecular formula was supported by the EI-MS, and 1 H and 13 C NMR spectroscopic analysis ( Table 1 ). The UV spectrum of 1 showed an absorption band at 230 nm, while the FTIR spectrum exhibited absorption bands for hydroxyl groups at 3340 cm -1 and for a secondary amide at 1624 and 1545 cm -1 . The 1 H NMR spectrum (Table 1) showed a doublet signal at δ H 8.57 (d, J = 9.0 Hz) attributed to a proton of an amide functional group. Two olefinic protons were observed as a multiplet at δ H 5.52-5.57 {m, H-C(14)=H-C(15)}. A methine resonance at δ H 5.09-5.13 {m, H-C(2)}, that corresponded in the HSQC spectrum with a carbon resonance at δ C 52.9 suggested its attachment to the amide function. Furthermore three oxygenated methine resonances at δ H 4.28 {s, H-C(4)}, 4.32-4.38 {m, H-C(3)}, 4.62 {t, J = 4, H-C(2')}, and an oxygenated methylene resonance at δ H 4.42 {dd, J = 9.5, 4, H a -C(1)} and 4.50 {dd, J = 10.5, 4, H b -C(1)} were observed. The 1 H NMR spectrum also displayed two long-chain aliphatic moieties appearing as a multiplets at δ H 1.25-1.33 and two terminal methyl groups at δ H 0.85 {t, J = 6.5 Hz, H-C(21), H-C(28')} indicating a sphingolipid skeleton [8] . The 13 C NMR spectrum ( Table 1) showed resonances at δ C 175.3 C(1') and 130.7 C(14-15) characteristic of a carbonyl group and two olefinic carbons, respectively. Three oxymethine resonances at δ C 76.6 C(3), 72.9 C(4) and 72.4 C(2') and one oxymethylene resonance at δ C 61.9 C(1) were also observed. Another methine carbon resonating at δ C 52.9 C(2) was due to the presence of an amidomethine functional group. These values were similar to the data reported for ceramide in the literature [8] . The length of the fatty acid and sphingosine chain was determined by chemical analysis, 1 H-and 2D-NMR spectra and characteristic fragment-ion peaks observed in the EI-MS and FAB-MS. 
The assignments were based upon 2D-COSY, HSQC, and HMBC spectra. .
The fatty acid chain was found to be composed of twenty-eight carbons from the EI-MS ( Fig. 3 ), which showed the ion peak at m/z = 423. Usually, the resonances of the carbons adjacent to a trans double bond appear at δ C 32-34 ppm, while those of a cis double bond appear at δ C 27-28 ppm [9] . The chemical shift of the H(2) signal at δ H 5.09-5.13 and the carbons signals at δ C 61.9 C(1), 52.9 C(2), 76.7 C(3), 72.9 C(4), 175.3 C(1') and 72.4 C(2') of compound 1 were similar to those of the previously reported ceramides [10] . Thus the structure of compound 1 was assigned as 2-hydroxy-N-1,3,4trihydroxyhenicos-14-en-2-yl) octacosanamide, trivially named as parinaramide.
Compound 2 was isolated as a yellow powder from the methanol fraction. The positive-ion ESIMS showed a quasi molecular ion peak at m/z = 919.2 [M+K] + . The molecular formula of C 42 H 40 O 21 , with twenty-three degrees of unsaturation, was deduced from the combination of EIMS, 1 H, 13 C and 2D NMR spectroscopic data ( Table 2 ). The UV spectrum showed absorption bands at 229, 266, 291, and 345 nm, characteristic of a flavonol skeleton [11] . The FTIR spectrum exhibited absorption bands for a hydroxyl group at 3404 cm -1 (broad) and a conjugated carbonyl function at 1647 cm -1 . Analysis of 1 H NMR and 13 
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The structures of the known compounds were established by comparing their spectral and physical data with those reported as kaempferol [12] , quercetin [12] , taxifolin [13] , taxifolin-3-Orhamnoside [13] , lupeol [14] , ursolic acid [14] , betulinic acid [15] , 2α-hydroxy-ursolic acid [16] , 2,3-dihydroxy-1-(4-hydroxy-3,5dimethoxyphenyl)-1-propanone [17] and sucrose [18] .
The antioxidant and lipoxygenase inhibition activities of MeOH extracts of stem bark, roots and leaves were determined in comparison with butylated hydroxyanisole (BHA) and bacelin as standards, respectively. chromatographic purification was carried out using silica gel (Kieselgel 60; 230-300 Mesh, 60 Ǻ Mesh) and Sephadex LH-20. All the solvents were distilled before use; compounds were detected using an UV-lamp and by spraying with ceric acid solution followed by heating. 
DPPH radical scavenging activity:
A serial dilution of the test fractions was made in either DMSO or methanol depending upon the best solubility and diluted to obtain final concentrations of 500, 250, 150, 125, 62.5, 31.2, 15.6, and 7.8 µM. A 0.3 mM solution of DPPH in ethanol was prepared and 90 µL of this was added to each well of a 96-well plate marked for control and test compounds. Then, 10 µL of each of the concentrations of the compound was added to the particular well to start the reaction. The contents of the wells were mixed for a few sec and then the mixture was incubated for 30 min at 37˚C and the absorbance measured at λ 517 by a micro titre plate reader (Spectra max plus 384 Molecular devices USA). The assay was standardized using butylated hydroxyanisole (BHA) prior to testing the compounds. Percent radical scavenging activity was determined in comparison with methanol treated control and IC 50 was calculated for each compound by EZ fit software (Perrella Software, USA).
Lipoxygenase inhibiting activity:
This was measured by modifying the spectrophotometric method developed by Tappel [19] . Lipoxygenase enzyme solution was prepared and the concentration of the reaction mixture was adjusted to give 130U per well. One hundred and sixty µL of 100 mM sodium phosphate buffer (pH 8.0) was added to each well of a plate labelled as blank (B substrate and B enzyme), control and test. Ten L of test compound solution in methanol (of various concentrations 5-500 M) was added to each well labelled as test. Twenty L of lipoxygenase (LOX) solution was added to each well including B (enzyme), control and test sample, except B (substrate). The contents were mixed and incubated for 10 min at 25C. Substrate solution was flushed with nitrogen gas to avoid auto oxidation before adding to each well. The reaction was then initiated by the addition of 10 L substrate solution (linoleic acid, 0.5 mM, 0.12 %, w/v, tween 20 in a ratio of 1:2) to each well, except B (enzyme), and the absorbance was measured and recorded at 234 nm. The concentration of the test compound that inhibited lipoxygenase activity by 50% (IC 50 ) was determined by monitoring the effect of increasing concentrations of these compounds in the assays on the degree of inhibition.
